1
|
Patry A, Bothorel P, Labrunie A, Renesme L, Lehours P, Benard M, Dubois D, Ponthier L, Meyer S, Norbert K, Villeneuve L, Jouvencel P, Leysenne D, Chainier D, Luce S, Grélaud C, Ploy MC, Bedu A, Garnier F. Dynamics of the digestive acquisition of bacterial carriage and integron presence by French preterm newborns according to maternal colonization: The DAIR3N multicentric study. Front Microbiol 2023; 14:1148319. [PMID: 36998410 PMCID: PMC10043237 DOI: 10.3389/fmicb.2023.1148319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Accepted: 02/21/2023] [Indexed: 03/15/2023] Open
Abstract
ObjectivesThe study aimed to describe the dynamics and risk factors of Gram-negative bacteria (GNB) acquisition in preterm infants.MethodsThis prospective multicenter French study included mothers hospitalized for preterm delivery and their newborns, followed until hospital discharge. Maternal feces and vaginal fluids at delivery, and neonatal feces from birth to discharge were tested for cultivable GNB, potential acquired resistance, and integrons. The primary outcome was the acquisition of GNB and integrons in neonatal feces, and their dynamics, evaluated by survival analysis using the actuarial method. Risk factors were analyzed using Cox models.ResultsTwo hundred thirty-eight evaluable preterm dyads were included by five different centers over 16 months. GNB were isolated in 32.6% of vaginal samples, with 15.4% of strains producing extended-spectrum beta-lactamase (ESBL) or hyperproducing cephalosporinase (HCase), and in 96.2% of maternal feces, with 7.8% ESBL-GNB or HCase-GNB. Integrons were detected in 40.2% of feces and 10.6% of GNB strains. The mean (SD) length of stay of newborns was 39.5 (15.9) days; 4 died in the hospital. At least one infection episode occurred in 36.1% of newborns. The acquisition of GNB and integrons was progressive from birth to discharge. At discharge, half of newborns had ESBL-GNB or HCase-GNB, independently favored by a premature rupture of membranes (Hazard Ratio (HR), 3.41, 95% confidence interval (CI), 1.71; 6.81), and 25.6% had integrons (protective factor: multiple gestation, HR, 0.367, 95% CI, 0.195; 0.693).ConclusionIn preterm newborns, the acquisitions of GNB, including resistant ones, and integrons are progressive from birth to discharge. A premature rupture of membranes favored the colonization by ESBL-GNB or Hcase-GNB.
Collapse
Affiliation(s)
- Alice Patry
- INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France
| | - Philippe Bothorel
- Department of Pediatrics, Mother-Child Hospital, Limoges University Hospital, Limoges, France
| | - Anaïs Labrunie
- Epidemiology, Biostatistics, and Research Methodology Centre (CEBIMER), Limoges University Hospital, Limoges, France
| | - Laurent Renesme
- Department of Pediatrics, Neonatology and Maternity Unit, Pellegrin University Hospital, Bordeaux, France
| | - Philippe Lehours
- Bacteriology Laboratory, Pellegrin University Hospital, Bordeaux, France
| | - Melinda Benard
- Department of Pediatrics and Neonatology, CHU Toulouse, Toulouse, France
| | - Damien Dubois
- Bacteriology and Hygiene Department, Federative Institute of Biology, CHU Toulouse University Hospital, Toulouse, France
| | - Laure Ponthier
- Department of Pediatrics, Mother-Child Hospital, Limoges University Hospital, Limoges, France
| | - Sylvain Meyer
- INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France
| | | | | | - Philippe Jouvencel
- Department of Pediatrics and Neonatology, « Côte Basque » Hospital, Bayonne, France
| | - David Leysenne
- Microbiology Laboratory, « Côte Basque » Hospital, Bayonne, France
| | - Delphine Chainier
- INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France
| | - Sandrine Luce
- Epidemiology, Biostatistics, and Research Methodology Centre (CEBIMER), Limoges University Hospital, Limoges, France
| | - Carole Grélaud
- INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France
| | - Marie-Cecile Ploy
- INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France
| | - Antoine Bedu
- Department of Pediatrics, Mother-Child Hospital, Limoges University Hospital, Limoges, France
| | - Fabien Garnier
- INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France
- *Correspondence: Fabien Garnier,
| |
Collapse
|
2
|
Tebani A, Sudrié-Arnaud B, Dabaj I, Torre S, Domitille L, Snanoudj S, Heron B, Levade T, Caillaud C, Vergnaud S, Saugier-Veber P, Coutant S, Dranguet H, Froissart R, Al Khouri M, Alembik Y, Baruteau J, Arnoux JB, Brassier A, Brehin AC, Busa T, Cano A, Chabrol B, Coubes C, Desguerre I, Doco-Fenzy M, Drenou B, Elcioglu NH, Elsayed S, Fouilhoux A, Poirsier C, Goldenberg A, Jouvencel P, Kuster A, Labarthe F, Lazaro L, Pichard S, Rivera S, Roche S, Roggerone S, Roubertie A, Sigaudy S, Spodenkiewicz M, Tardieu M, Vanhulle C, Marret S, Bekri S. Disentangling molecular and clinical stratification patterns in beta-galactosidase deficiency. J Med Genet 2021; 59:377-384. [PMID: 33737400 DOI: 10.1136/jmedgenet-2020-107510] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2020] [Revised: 01/16/2021] [Accepted: 01/19/2021] [Indexed: 11/04/2022]
Abstract
INTRODUCTION This study aims to define the phenotypic and molecular spectrum of the two clinical forms of β-galactosidase (β-GAL) deficiency, GM1-gangliosidosis and mucopolysaccharidosis IVB (Morquio disease type B, MPSIVB). METHODS Clinical and genetic data of 52 probands, 47 patients with GM1-gangliosidosis and 5 patients with MPSIVB were analysed. RESULTS The clinical presentations in patients with GM1-gangliosidosis are consistent with a phenotypic continuum ranging from a severe antenatal form with hydrops fetalis to an adult form with an extrapyramidal syndrome. Molecular studies evidenced 47 variants located throughout the sequence of the GLB1 gene, in all exons except 7, 11 and 12. Eighteen novel variants (15 substitutions and 3 deletions) were identified. Several variants were linked specifically to early-onset GM1-gangliosidosis, late-onset GM1-gangliosidosis or MPSIVB phenotypes. This integrative molecular and clinical stratification suggests a variant-driven patient assignment to a given clinical and severity group. CONCLUSION This study reports one of the largest series of b-GAL deficiency with an integrative patient stratification combining molecular and clinical features. This work contributes to expand the community knowledge regarding the molecular and clinical landscapes of b-GAL deficiency for a better patient management.
Collapse
Affiliation(s)
- Abdellah Tebani
- Department of Metabolic Biochemistry, Rouen University Hospital, Rouen, France.,Normandie Univ, UNIROUEN, CHU Rouen, INSERM U1245, 76000 Rouen, Normandy Center for Genomic and Personalized Medicine, Rouen, France
| | | | - Ivana Dabaj
- Normandie Univ, UNIROUEN, CHU Rouen, INSERM U1245, 76000 Rouen, Normandy Center for Genomic and Personalized Medicine, Rouen, France.,Department of Neonatal Pediatrics, Intensive Care and Neuropediatrics, Rouen University Hospital, Rouen, France
| | - Stéphanie Torre
- Department of Neonatal Pediatrics, Intensive Care and Neuropediatrics, Rouen University Hospital, Rouen, France
| | - Laur Domitille
- Pediatric Neurology Department, Robert Debré Hospital, Public Hospital Network of Paris, Paris, France
| | - Sarah Snanoudj
- Department of Metabolic Biochemistry, Rouen University Hospital, Rouen, France.,Normandie Univ, UNIROUEN, CHU Rouen, INSERM U1245, 76000 Rouen, Normandy Center for Genomic and Personalized Medicine, Rouen, France
| | - Benedicte Heron
- Reference Center for Lysosomal Diseases, Pediatric Neurology Department, UH Armand Trousseau-La Roche Guyon, APHP, GUEP, Paris, France
| | - Thierry Levade
- Laboratoire de Biochimie Métabolique, Institut Fédératif de Biologie, CHU Purpan, Toulouse, France.,Cancer Research Center, INSERM UMR1037 CRCT, Toulouse, France
| | - Catherine Caillaud
- Biochemistry, Metabolomic and Proteomic Department, Necker Enfants Malades University Hospital, Assistance Publique Hôpitaux de Paris, UMRS 1151, INSERM, Institute Necker Enfants Malades, Paris Descartes University, Paris, France
| | - Sabrina Vergnaud
- UF Maladies Héréditaires Enzymatiques Rares-CGD, Institut de Biologie et de Pathologies, CHU de Grenoble Alpes, Grenoble, France
| | - Pascale Saugier-Veber
- Normandie Univ, UNIROUEN, CHU Rouen, INSERM U1245, 76000 Rouen, Normandy Center for Genomic and Personalized Medicine, Rouen, France
| | - Sophie Coutant
- Department of Genetics, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, F76000, Normandy Centre for Genomic and Personalized Medicine, ROUEN, France
| | - Hélène Dranguet
- Department of Metabolic Biochemistry, Rouen University Hospital, Rouen, France
| | - Roseline Froissart
- Biochemical and Molecular Biology Department, Centre de Biologie et de Pathologie Est Hospices Civils de Lyon, Lyon, France
| | - Majed Al Khouri
- Department of Pediatric Gastroenterology, hepatology and Nutrition, University hospital of Montpellier, Montpellier, France
| | - Yves Alembik
- Department of Clinical Genetic, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | - Julien Baruteau
- Metabolic Medicine Department, Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street Institute of Child Health, University College London, London, UK
| | - Jean-Baptiste Arnoux
- Department of Inherited Metabolic Disease, Necker-Enfants Malades University Hospital, AP-HP, Paris, France
| | - Anais Brassier
- Reference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, Imagine Institute, University Paris Descartes, Paris, France
| | - Anne-Claire Brehin
- Normandie Univ, UNIROUEN, CHU Rouen, INSERM U1245, 76000 Rouen, Normandy Center for Genomic and Personalized Medicine, Rouen, France
| | - Tiffany Busa
- Département de Génétique Médicale, Hôpital Timone Enfant, Marseille, France
| | - Aline Cano
- Centre de Référence des Maladies Héréditaires du Métabolisme, Service de Neuropédiatrie, CHU La Timone Enfants, APHM, Marseille, France
| | - Brigitte Chabrol
- Centre de Référence des Maladies Héréditaires du Métabolisme, Service de Neuropédiatrie, CHU La Timone Enfants, APHM, Marseille, France
| | - Christine Coubes
- Genetic Services, A. de Villeneuve Hospital, Montpellier, France
| | - Isabelle Desguerre
- Department of Paediatric Neurology, Hopital universitaire Necker-Enfants malades Service de Pediatrie generale, Paris, Île-de-France, France
| | - Martine Doco-Fenzy
- Service de génétique, CHRU Reims, Reims, France.,EA3801, UFR médecine, France
| | - Bernard Drenou
- Department of Hematolog, Hôpital Emile Muller - CH de Mulhouse, Mulhouse, France
| | - Nursel H Elcioglu
- Pediatric Genetics, Marmara University Medical School, Istanbul, Turkey
| | - Solaf Elsayed
- Genetics, Children's Hospital, Ain Shams University, Cairo, Egypt
| | - Alain Fouilhoux
- Department of Pediatric Metabolism, Reference Center of Inherited Metabolic Disorders, Femme Mère Enfant Hospital, Lyon, France
| | - Céline Poirsier
- Genetic department, CHU-Reims, EA3801, SFR CAP santé, Reims, France
| | - Alice Goldenberg
- Department of Genetics, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, F76000, Normandy Centre for Genomic and Personalized Medicine, ROUEN, France
| | - Philippe Jouvencel
- Department of Neonatology and Paediatrics, Centre Hospitalier de la Côte Basque, Bayonne, France
| | - Alice Kuster
- Pediatric Critical Care Unit, Femme-Enfants-Adolescents Hospital, Nantes University, Nantes, France
| | | | - Leila Lazaro
- Department of Neonatology and Paediatrics, Centre Hospitalier de la Côte Basque, Bayonne, France
| | - Samia Pichard
- Reference Centre for Inborn Errors of Metabolism, Robert-Debré University Hospital, APHP, Paris, France
| | - Serge Rivera
- Department of Neonatology and Paediatrics, Centre Hospitalier de la Côte Basque, Bayonne, France
| | - Sandrine Roche
- Department of Pediatrics, Bordeaux University Hospital, Bordeaux, France
| | | | - Agathe Roubertie
- INSERM U 1051, Institut des Neurosciences de Montpellier, Montpellier, Hérault, France.,Département de Neuropédiatrie, CHU Gui de Chauliac, Montpellier, France
| | - Sabine Sigaudy
- Genetics, Hôpital d'Enfants de la Timone, Marseille, France
| | | | - Marine Tardieu
- Department of Pediatrics, Reference Center of Inherited Metabolic Disorders, Clocheville Hospital, Tours, France
| | - Catherine Vanhulle
- Department of Neonatal Pediatrics, Intensive Care and Neuropediatrics, Rouen University Hospital, Rouen, France
| | - Stéphane Marret
- Normandie Univ, UNIROUEN, CHU Rouen, INSERM U1245, 76000 Rouen, Normandy Center for Genomic and Personalized Medicine, Rouen, France.,Department of Neonatal Pediatrics, Intensive Care and Neuropediatrics, Rouen University Hospital, Rouen, France
| | - Soumeya Bekri
- Normandie Univ, UNIROUEN, CHU Rouen, INSERM U1245, 76000 Rouen, Normandy Center for Genomic and Personalized Medicine, Rouen, France .,Department of Metabolic Biochemistry, University Hospital Centre Rouen, Rouen, Normandie, France
| |
Collapse
|
3
|
Decalonne M, Dos Santos S, Gimenes R, Goube F, Abadie G, Aberrane S, Ambrogi V, Baron R, Barthelemy P, Bauvin I, Belmonte O, Benabid E, Ammar RB, Yahia SBH, Berrouane Y, Berthelot P, Beuchee A, Bille E, Bolot P, Bordes-Couecou S, Bouissou A, Bourdon S, Bourgeois-Nicolaos N, Boyer S, Cattoen C, Cattoir V, Chaplain C, Chatelet C, Claudinon A, Chautemps N, Cormier H, Coroller-Bec C, Cotte B, De Chillaz C, Dauwalder O, Davy A, Delorme M, Demasure M, Desfrere L, Drancourt M, Dupin C, Faraut-Derouin V, Florentin A, Forget V, Fortineau N, Foucan T, Frange P, Gambarotto K, Gascoin G, Gibert L, Gilquin J, Glanard A, Grando J, Gravet A, Guinard J, Hery-Arnaud G, Huart C, Idri N, Jellimann JM, Join-Lambert O, Joron S, Jouvencel P, Kempf M, Ketterer-Martinon S, Khecharem M, Klosowski S, Labbe F, Lacazette A, Lapeyre F, Larche J, Larroude P, Le Pourhiennec A, Le Sache N, Ledru S, Lefebvre A, Legeay C, Lemann F, Lesteven C, Levast-Raffin M, Leyssene D, Ligi I, Lozniewski A, Lureau P, Mallaval FO, Malpote E, Marret S, Martres P, Menard G, Menvielle L, Mereghetti L, Merle V, Minery P, Morange V, Mourdie J, Muggeo A, Nakhleh J, Noulard MN, Olive C, Patural H, Penn P, Petitfrere M, Pozetto B, Riviere B, Robine A, Ceschin CR, Ruimy R, Siali A, Soive S, Slimani S, Trentesaux AS, Trivier D, Vandenbussche C, Villeneuve L, Werner E, Le Vu S, Van Der Mee-Marquet N. Staphylococcus capitis isolated from bloodstream infections: a nationwide 3-month survey in 38 neonatal intensive care units. Eur J Clin Microbiol Infect Dis 2020; 39:2185-2194. [PMID: 32519215 PMCID: PMC7561542 DOI: 10.1007/s10096-020-03925-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Accepted: 05/03/2020] [Indexed: 11/24/2022]
Abstract
To increase the knowledge about S. capitis in the neonatal setting, we conducted a nationwide 3-month survey in 38 neonatal intensive care units (NICUs) covering 56.6% of French NICU beds. We demonstrated 14.2% of S. capitis BSI (S.capBSI) among nosocomial BSIs. S.capBSI incidence rate was 0.59 per 1000 patient-days. A total of 55.0% of the S.capBSIs were late onset catheter-related BSIs. The S. capitis strains infected preterm babies (median gestational age 26 weeks, median birth weight 855 g). They were resistant to methicillin and aminoglycosides and belonged to the NRCS-A clone. Evolution was favorable in all but one case, following vancomycin treatment.
Collapse
Affiliation(s)
- Marie Decalonne
- SPIADI, CPIAS CVDL, Hôpital Bretonneau, Centre Hospitalier Universitaire, 37044, Tours, France
| | - Sandra Dos Santos
- Cellule d'Epidémiologie Régionale des Infections Nosocomiales, CPIAS CVDL, Service de Bactériologie-Virologie-Hygiène, Hôpital Trousseau, CHRU, 37044, Tours, France
| | - Rémi Gimenes
- SPIADI, CPIAS CVDL, Hôpital Bretonneau, Centre Hospitalier Universitaire, 37044, Tours, France
| | - Florent Goube
- SPIADI, CPIAS CVDL, Hôpital Bretonneau, Centre Hospitalier Universitaire, 37044, Tours, France
| | - Géraldine Abadie
- Service de réanimation néonatale, Centre Hospitalier Universitaire Félix Guyon, 97400, Saint Denis de la Réunion, France
| | - Saïd Aberrane
- Laboratoire de Microbiologie, Centre Hospitalier Inter-Communal, 94010, Créteil, France
| | - Vanina Ambrogi
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire, 31059, Toulouse, France
| | - Raoul Baron
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire, 29609, Brest, France
| | - Patrick Barthelemy
- Équipe opérationnelle d'hygiène, Hôpital de la Conception, APHM, 13005, Marseille, France
| | - Isabelle Bauvin
- Service de réanimation néonatale, Centre Hospitalier, 64000, Pau, France
| | - Olivier Belmonte
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire Félix Guyon, 97400, Saint Denis de la Réunion, France
| | - Emilie Benabid
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 95300, Pontoise, France
| | - Rafik Ben Ammar
- Service de réanimation néonatale, Centre Hospitalier Universitaire Antoine-Béclère, APHP, 92140, Clamart, France
| | | | - Yasmina Berrouane
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire, 06200, Nice, France
| | - Philippe Berthelot
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire, 42055, Saint Etienne, France
| | - Alain Beuchee
- Service de réanimation néonatale, Centre Hospitalier Universitaire, 35000, Rennes, France
| | - Emmanuelle Bille
- Laboratoire de Microbiologie clinique, Hôpital universitaire Necker-Enfants malades, APHP, 75015, Paris, France
| | - Pascal Bolot
- Service de réanimation néonatale, Centre Hospitalier Delafontaine, 93205, Saint Denis, France
| | | | - Antoine Bouissou
- Service de réanimation néonatale, Centre Hospitalier Universitaire, 37044, Tours, France
| | - Sandra Bourdon
- Équipe opérationnelle d'hygiène, Centre Hospitalier du Havre, 76290, Montivilliers, France
| | - Nadège Bourgeois-Nicolaos
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire Antoine-Béclère, APHP, 92140, Clamart, France
| | - Sophie Boyer
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire Charles Nicolle, 76000, Rouen, France
| | - Christian Cattoen
- Laboratoire de Microbiologie, Centre Hospitalier, 59300, Valenciennes, France
| | - Vincent Cattoir
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire, 35000, Rennes, France
| | - Chantal Chaplain
- Laboratoire de Microbiologie, Centre Hospitalier Delafontaine, 93205, Saint Denis, France
| | - Céline Chatelet
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 62300, Lens, France
| | - Aurore Claudinon
- Laboratoire de Microbiologie, Centre Hospitalier, 95107, Argenteuil, France
| | - Nathalie Chautemps
- Service de réanimation néonatale, Centre Hospitalier Métropole Savoie-Site de Chambéry, 73 011, Chambéry, France
| | - Hélène Cormier
- UPLIN, Centre Hospitalier Universitaire, 49933, Angers, France
| | | | | | - Carole De Chillaz
- Service de Néonatalogie et Réanimation néonatale, Hôpital universitaire Necker-Enfants malades, APHP, 75015, Paris, France
| | - Olivier Dauwalder
- Laboratoire de Microbiologie, Hôpitaux Civils de Lyon, 69677, Bron, France
| | - Aude Davy
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 22000, Saint Brieuc, France
| | - Martine Delorme
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 79021, Niort, France
| | - Maryvonne Demasure
- Équipe opérationnelle d'hygiène, Centre Hospitalier Régional, 45100, Orléans, France
| | - Luc Desfrere
- Service de réanimation néonatale, Centre Hospitalier Universitaire, Hôpital Louis-Mourier, APHP, 92700, Colombes, France
| | - Michel Drancourt
- Laboratoire de Microbiologie, Hôpital de la Conception, APHM, 13005, Marseille, France
| | - Clarisse Dupin
- Laboratoire de Microbiologie, Centre Hospitalier, 22000, Saint Brieuc, France
| | - Véronique Faraut-Derouin
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire Antoine-Béclère, APHP, 92140, Clamart, France
| | - Arnaud Florentin
- Service d'hygiène et d'analyses environnementales (SHAE), Hôpitaux de Brabois, 54035, Nancy, France
| | - Virginie Forget
- Équipe opérationnelle d'hygiène, Centre Hospitalier Métropole Savoie-Site de Chambéry, 73 011, Chambéry, France
| | - Nicolas Fortineau
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire, Kremlin Bicêtre, APHP, 94275, Le Kremlin Bicêtre, France
| | - Tania Foucan
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire, 97159, Pointe-à-Pitre, France
| | - Pierre Frange
- Laboratoire de Microbiologie clinique, Hôpital universitaire Necker-Enfants malades, APHP, 75015, Paris, France.,Équipe opérationnelle d'hygiène, Hôpital universitaire Necker-Enfants malades, APHP, 75015, Paris, France
| | - Karine Gambarotto
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire Félix Guyon, 97400, Saint Denis de la Réunion, France
| | - Géraldine Gascoin
- Service de réanimation néonatale, Centre Hospitalier Universitaire, 49933, Angers, France
| | - Laure Gibert
- Équipe opérationnelle d'hygiène, Centre Hospitalier du Havre, 76290, Montivilliers, France
| | - Jacques Gilquin
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 81100, Castres, France
| | - Audrey Glanard
- Équipe opérationnelle d'hygiène, Centre Hospitalier Delafontaine, 93205, Saint Denis, France
| | - Jacqueline Grando
- Équipe opérationnelle d'hygiène, Hôpitaux Civils de Lyon, 69677, Bron, France
| | - Alain Gravet
- Laboratoire de Microbiologie, Centre Hospitalier, 68100, Mulhouse, France
| | - Jérôme Guinard
- Laboratoire de Microbiologie, Centre Hospitalier Régional, 45100, Orléans, France
| | - Geneviève Hery-Arnaud
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire, 29609, Brest, France
| | - Claire Huart
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 59300, Valenciennes, France
| | - Nadia Idri
- Équipe opérationnelle d'hygiène, Hôpital Louis-Mourier, APHP, 92700, Colombes, France.,Laboratoire de Microbiologie, Hôpital Louis-Mourier, APHP, 92700, Colombes, France
| | - Jean-Marc Jellimann
- Service de réanimation néonatale, Centre Hospitalier Universitaire, Hôpitaux de Brabois, 54035, Nancy, France
| | - Olivier Join-Lambert
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire, 14000, Caen, France
| | - Sylvie Joron
- Service d'hygiène, Centre Hospitalier, 62100, Calais, France
| | - Philippe Jouvencel
- Service de réanimation néonatale, Centre Hospitalier, 64100, Bayonne, France
| | - Marie Kempf
- Laboratoire de Bactériologie-Hygiène Institut de Biologie en Santé, CRCINA Inserm U1232, Université d'Angers, Centre Hospitalier Universitaire, 49933, Angers, France
| | - Sophie Ketterer-Martinon
- Service de réanimation néonatale et réanimation pédiatrique, Centre Hospitalier Universitaire de Martinique, 97261, Fort de France, France
| | - Mouna Khecharem
- Laboratoire de Bactériologie-Hygiène, Centre Hospitalier Universitaire, Kremlin Bicêtre, APHP, 94275, Le Kremlin Bicêtre, France
| | - Serge Klosowski
- Service de réanimation néonatale, Centre Hospitalier, 62300, Lens, France
| | - Franck Labbe
- Laboratoire de Microbiologie, Centre Hospitalier du Havre, 76290, Montivilliers, France
| | - Adeline Lacazette
- Service de réanimation néonatale, Centre Hospitalier Universitaire, 97159, Pointe-à-Pitre, France
| | - Fabrice Lapeyre
- Service de réanimation néonatale, Centre Hospitalier, 59300, Valenciennes, France
| | | | - Peggy Larroude
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 64000, Pau, France
| | | | - Nolwenn Le Sache
- Service de réanimation néonatale, Centre Hospitalier Universitaire, Kremlin Bicêtre, APHP, 94275, Le Kremlin Bicêtre, France
| | - Sylvie Ledru
- Laboratoire de Microbiologie, Centre Hospitalier, 62300, Lens, France
| | - Annick Lefebvre
- Équipe opérationnelle d'hygiène, Université de Reims Champagne-Ardenne, 51100, Reims, France
| | - Clément Legeay
- UPLIN, Centre Hospitalier Universitaire, 49933, Angers, France
| | - Florence Lemann
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 95107, Argenteuil, France
| | - Claire Lesteven
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire, 14000, Caen, France
| | - Marion Levast-Raffin
- Laboratoire de Biologie Médicale, Centre Hospitalier Métropole Savoie-Site de Chambéry, 73 011, Chambéry, France
| | - David Leyssene
- Laboratoire de Microbiologie, Centre Hospitalier, 64100, Bayonne, France
| | - Isabelle Ligi
- Service de réanimation néonatale, Centre Hospitalier Universitaire, Hôpital de la Conception, APHM, 13005, Marseille, France
| | - Alain Lozniewski
- Laboratoire de Microbiologie, Hôpitaux de Brabois, 54035, Nancy, France
| | - Pierre Lureau
- Laboratoire de Microbiologie, Centre Hospitalier, 79021, Niort, France
| | - Franck-Olivier Mallaval
- Équipe opérationnelle d'hygiène, Centre Hospitalier Métropole Savoie-Site de Chambéry, 73 011, Chambéry, France
| | - Edith Malpote
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire, 97159, Pointe-à-Pitre, France
| | - Stéphane Marret
- Service de réanimation néonatale, Centre Hospitalier Universitaire Charles Nicolle, 76000, Rouen, France
| | - Pascale Martres
- Laboratoire de Microbiologie, Centre Hospitalier, 95300, Pontoise, France
| | - Guillaume Menard
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire, 35000, Rennes, France
| | - Laura Menvielle
- Service de réanimation néonatale et réanimation pédiatrique, Centre Hospitalier Universitaire, Hôpital Robert Debré, Inserm UMR-S 1250 P3Cell, Université de Reims Champagne-Ardenne, 51100, Reims, France
| | - Laurent Mereghetti
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire, 37044, Tours, France
| | - Véronique Merle
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire Charles Nicolle, 76000, Rouen, France
| | - Pascale Minery
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 68100, Mulhouse, France
| | - Virginie Morange
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire, 37044, Tours, France
| | - Julien Mourdie
- Service de réanimation néonatale, Centre Hospitalier du Havre, 76290, Montivilliers, France
| | - Anaelle Muggeo
- Laboratoire de Bactériologie, Université de Reims Champagne-Ardenne, 51100, Reims, France
| | - Jean Nakhleh
- Service de réanimation néonatale, Centre Hospitalier, 68100, Mulhouse, France
| | | | - Claude Olive
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire de Martinique, 97261, Fort de France, France
| | - Hugues Patural
- Service de réanimation néonatale, Centre Hospitalier Universitaire, 42055, Saint Etienne, France
| | - Pascale Penn
- Laboratoire de Microbiologie, Centre Hospitalier, 72000, Le Mans, France
| | | | - Bruno Pozetto
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire, 42055, Saint Etienne, France
| | - Brigitte Riviere
- Laboratoire de Microbiologie, Centre Hospitalier, 81100, Castres, France
| | - Audrey Robine
- Service de réanimation néonatale, Centre Hospitalier, 72000, Le Mans, France
| | | | - Raymond Ruimy
- Laboratoire de Microbiologie, Centre Hospitalier Universitaire, 06200, Nice, France
| | - Amine Siali
- Équipe opérationnelle d'hygiène, Centre Hospitalier Inter-Communal, 94010, Créteil, France
| | - Stéphanie Soive
- Service de réanimation néonatale, Centre Hospitalier, 22000, Saint Brieuc, France
| | - Souad Slimani
- Équipe opérationnelle d'hygiène, Centre Hospitalier Universitaire de Martinique, 97261, Fort de France, France
| | | | - Dominique Trivier
- Équipe opérationnelle d'hygiène, Centre Hospitalier, 62300, Lens, France
| | | | | | - Evelyne Werner
- Service de réanimation néonatale, Centre Hospitalier Régional, 45100, Orléans, France
| | - Stéphane Le Vu
- Agence Santé Publique France, 94415, Saint Maurice, France
| | - Nathalie Van Der Mee-Marquet
- SPIADI, CPIAS CVDL, Hôpital Bretonneau, Centre Hospitalier Universitaire, 37044, Tours, France. .,Cellule d'Epidémiologie Régionale des Infections Nosocomiales, CPIAS CVDL, Service de Bactériologie-Virologie-Hygiène, Hôpital Trousseau, CHRU, 37044, Tours, France.
| |
Collapse
|
4
|
Larricq D, Hoquet PM, Magdelaine C, Embarek Cayla C, Jouvencel P, Beguet M, Besiers C, Bouton M, Nataf J. Incompatibilité fœto-maternelle à l’antigène Dombrock 1. Transfus Clin Biol 2017. [DOI: 10.1016/j.tracli.2017.06.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
5
|
Carrozzo R, Verrigni D, Rasmussen M, de Coo R, Amartino H, Bianchi M, Buhas D, Mesli S, Naess K, Born AP, Woldseth B, Prontera P, Batbayli M, Ravn K, Joensen F, Cordelli DM, Santorelli FM, Tulinius M, Darin N, Duno M, Jouvencel P, Burlina A, Stangoni G, Bertini E, Redonnet-Vernhet I, Wibrand F, Dionisi-Vici C, Uusimaa J, Vieira P, Osorio AN, McFarland R, Taylor RW, Holme E, Ostergaard E. Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients. J Inherit Metab Dis 2016; 39:243-52. [PMID: 26475597 DOI: 10.1007/s10545-015-9894-9] [Citation(s) in RCA: 60] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2015] [Revised: 09/04/2015] [Accepted: 09/08/2015] [Indexed: 11/28/2022]
Abstract
BACKGROUND The encephalomyopathic mtDNA depletion syndrome with methylmalonic aciduria is associated with deficiency of succinate-CoA ligase, caused by mutations in SUCLA2 or SUCLG1. We report here 25 new patients with succinate-CoA ligase deficiency, and review the clinical and molecular findings in these and 46 previously reported patients. PATIENTS AND RESULTS Of the 71 patients, 50 had SUCLA2 mutations and 21 had SUCLG1 mutations. In the newly-reported 20 SUCLA2 patients we found 16 different mutations, of which nine were novel: two large gene deletions, a 1 bp duplication, two 1 bp deletions, a 3 bp insertion, a nonsense mutation and two missense mutations. In the newly-reported SUCLG1 patients, five missense mutations were identified, of which two were novel. The median onset of symptoms was two months for patients with SUCLA2 mutations and at birth for SUCLG1 patients. Median survival was 20 years for SUCLA2 and 20 months for SUCLG1. Notable clinical differences between the two groups were hepatopathy, found in 38% of SUCLG1 cases but not in SUCLA2 cases, and hypertrophic cardiomyopathy which was not reported in SUCLA2 patients, but documented in 14% of cases with SUCLG1 mutations. Long survival, to age 20 years or older, was reported in 12% of SUCLA2 and in 10% of SUCLG1 patients. The most frequent abnormality on neuroimaging was basal ganglia involvement, found in 69% of SUCLA2 and 80% of SUCLG1 patients. Analysis of respiratory chain enzyme activities in muscle generally showed a combined deficiency of complexes I and IV, but normal histological and biochemical findings in muscle did not preclude a diagnosis of succinate-CoA ligase deficiency. In five patients, the urinary excretion of methylmalonic acid was only marginally elevated, whereas elevated plasma methylmalonic acid was consistently found. CONCLUSIONS To our knowledge, this is the largest study of patients with SUCLA2 and SUCLG1 deficiency. The most important findings were a significantly longer survival in patients with SUCLA2 mutations compared to SUCLG1 mutations and a trend towards longer survival in patients with missense mutations compared to loss-of-function mutations. Hypertrophic cardiomyopathy and liver involvement was exclusively found in patients with SUCLG1 mutations, whereas epilepsy was much more frequent in patients with SUCLA2 mutations compared to patients with SUCLG1 mutations. The mutation analysis revealed a number of novel mutations, including a homozygous deletion of the entire SUCLA2 gene, and we found evidence of two founder mutations in the Scandinavian population, in addition to the known SUCLA2 founder mutation in the Faroe Islands.
Collapse
Affiliation(s)
- Rosalba Carrozzo
- Unit of Muscular and Neurodegenerative Diseases, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Daniela Verrigni
- Unit of Muscular and Neurodegenerative Diseases, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Magnhild Rasmussen
- Department of Clinical Neurosciences for Children, Oslo University Hospital, Oslo, Norway
| | - Rene de Coo
- Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands
| | - Hernan Amartino
- Servicio de Neurología Infantil, Hospital Universitario Austral, Buenos Aires, Argentina
| | - Marzia Bianchi
- Unit of Muscular and Neurodegenerative Diseases, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Daniela Buhas
- Department of Medical Genetics, Montreal Children's Hospital, Montréal, Quebéc, Canada
| | - Samir Mesli
- Biochemistry, CHU de Bordeaux, Bordeaux, France
| | - Karin Naess
- Department of Laboratory Medicine and Centre for Inherited Metabolic Diseases, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
| | - Alfred Peter Born
- Department of Pediatrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
| | - Berit Woldseth
- Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway
| | - Paolo Prontera
- Centro di Riferimento Regionale di Genetica Medica, Azienda Ospedaliera di Perugia, CREO, Perugia, Italy
| | - Mustafa Batbayli
- Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
| | - Kirstine Ravn
- Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
| | - Fróði Joensen
- Department of Pediatrics, National Hospital of the Faroe Islands, Tórshavn, Faroe Islands
| | - Duccio M Cordelli
- U.O. Neuropsichiatria Infantile - Franzoni, Policlinico S. Orsola Malpighi, Bologna, Italy
| | | | - Mar Tulinius
- Department of Pediatrics, University of Gothenburg, The Queen Silvia's Children Hospital, Gothenburg, Sweden
| | - Niklas Darin
- Department of Pediatrics, University of Gothenburg, The Queen Silvia's Children Hospital, Gothenburg, Sweden
| | - Morten Duno
- Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
| | - Philippe Jouvencel
- Neonatal and Pediatric Intensive Care Unit, Children's Hospital, Bordeaux, France
| | - Alberto Burlina
- Division of Inherited Metabolic Diseases, Department of Pediatrics, University Hospital of Padua, Padua, Italy
| | - Gabriela Stangoni
- Centro di Riferimento Regionale di Genetica Medica, Azienda Ospedaliera di Perugia, CREO, Perugia, Italy
| | - Enrico Bertini
- Unit of Muscular and Neurodegenerative Diseases, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | | | - Flemming Wibrand
- Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
| | - Carlo Dionisi-Vici
- Division of Metabolism, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Johanna Uusimaa
- Institute of Clinical Medicine/Department of Paediatrics, Finland and Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland
| | - Paivi Vieira
- Institute of Clinical Medicine/Department of Paediatrics, Finland and Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland
| | - Andrés Nascimento Osorio
- Unidad de patología neuromuscular, Servicio de Neurología, Hospital Sant Joan de Déu. Hospital Sant Joan de Déu and CIBERER, ISCIII, Barcelona, Spain
| | - Robert McFarland
- Wellcome Trust Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK
| | - Robert W Taylor
- Wellcome Trust Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK
| | - Elisabeth Holme
- Department of Clinical Chemistry, Institute of Biomedicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
| | - Elsebet Ostergaard
- Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
| |
Collapse
|
6
|
Brissaud O, Harper L, Lamireau D, Jouvencel P, Fayon M. Sonography-guided positioning of intravenous long lines in neonates. Eur J Radiol 2009; 74:e18-21. [PMID: 19369018 DOI: 10.1016/j.ejrad.2009.03.017] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2008] [Revised: 12/04/2008] [Accepted: 03/10/2009] [Indexed: 02/01/2023]
Abstract
OBJECTIVE In neonates, proper positioning of the tip of intravenous long lines (LL) is essential in order to prevent potential life-threatening complications. The gold standard for the evaluation of LL position in neonates is the chest X-ray with or without contrast. We performed a prospective study to assess the use of transthoracic ultrasonography (US) for the positioning of LL in neonates and to compare it to plain radiography. MATERIALS AND METHOD Thirty-six consecutive neonates requiring percutaneous LL over a period of 3 months were included in the study. Immediately after LL insertion, the position of its tip was verified using transthoracic US, followed by plain radiography. The two techniques were compared in terms of adequate placement and length of time between insertion and radiographic evaluation of the correct position. RESULTS The correlation between positioning by US and plain radiography was very good (r=0.97, r(2)=0.94, p<0.0001). The time needed to verify LL placement by US was shorter by a mean 15 min compared to plain radiography. CONCLUSION US can accurately guide LL tip positioning. We believe that because of the potential gain of time it offers and its lack of ionising radiation, it to be considered as an interesting tool for the positioning of LL in neonates. Yet more accurate results could be obtained with a better-trained staff.
Collapse
Affiliation(s)
- Olivier Brissaud
- Neonatal and Pediatric Intensive Care Unit, Children's Hospital, Bordeaux, France.
| | | | | | | | | |
Collapse
|
7
|
|
8
|
Cabasson S, Godron A, Bordes-Couecou S, Hernandorena X, Jouvencel P. Infection nosocomiale fatale chez un nouveau-né prématuré liée à une contamination par un tire-lait. Arch Pediatr 2007; 14:294-5. [PMID: 17258440 DOI: 10.1016/j.arcped.2006.12.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2006] [Accepted: 12/07/2006] [Indexed: 10/23/2022]
|
9
|
Lacoste A, Torregrosa A, Dubois S, Apéré H, Oyharçabal V, Carré M, Cayla-Embarek C, Hernandoréna X, Jouvencel P. Choc toxique staphylococcique maternofœtal sur chorioamniotite. Arch Pediatr 2006; 13:1132-4. [PMID: 16797947 DOI: 10.1016/j.arcped.2006.04.022] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2005] [Accepted: 04/19/2006] [Indexed: 11/15/2022]
Abstract
We report a rare case of mother-infant pair with Staphylococcal Toxic Shock Syndrome (TSS). A term neonate was born by caesarean section for maternal septic syndrome during per-partum. He presented with respiratory distress complicated by pulmonary hypertension, skin rash, and multiple organ system involvement. Staphylococcus aureus was isolated from placenta, surface swabs and gastric aspirate. He received adapted antibiotics, respiratory support by high frequency ventilation and NO. The mother had shock, skin rash and inflammatory syndrome. Outcome was good in both cases. The isolate produced enterotoxin C and L. Shock, exanthematous disease and multi-organ involvement complicating a staphylococcal infection in neonate must lead to suspect a TSS.
Collapse
Affiliation(s)
- A Lacoste
- Service de pédiatrie et néonatologie, centre hospitalier de la Côte-Basque, 13, avenue Interne-J.-Loëb, 64100 Bayonne, France
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Abstract
OBJECTIVE Little is known about the use of generic severity scores in severe childhood infectious diseases. The purpose of this prospective study was to evaluate the performance of the Pediatric Risk of Mortality (PRISM) scoring system in predicting the outcome of falciparum malaria in African children. DESIGN, SETTING, PATIENTS All children admitted to a 120-bed pediatric ward in a tertiary care hospital in Dakar, Senegal, with a primary diagnosis of acute malaria were assigned a PRISM score after 24 hrs or at time of death. INTERVENTIONS None. RESULTS PRISM discrimination, evaluated by areas under receiver operating characteristic curves (AUC), was good both for all acute malaria cases (n = 311; lethality, 9%; AUC, 0.89; 95% confidence interval [CI], 0.85-0.92) and for severe malaria cases (n = 233; lethality, 12%; AUC, 0.86; 95% CI, 0.81-0.90). However, the number of children who died was greater than the number of deaths predicted by PRISM (standardized mortality ratio, 2.16; 95% CI, 1.46-2.87). CONCLUSION This discrepancy observed in five classes of expected mortality (Hosmer-Lemeshow chi-square test, p < .001) may have been due to chance (sample size too small for a valid test), to a lower standard of care in Dakar than in the American hospitals where PRISM was designed, or to a failure of PRISM to classify risk in severe malaria.
Collapse
Affiliation(s)
- Patrick Gérardin
- Department of Pediatrics, Hôpital Principal, Dakar, Senegal, Neonatal and Pediatric Intensive Care Unit, Hôpital de Terre-Sainte, Saint-Pierre, Reunion Island, France
| | | | | | | | | | | |
Collapse
|
11
|
Jouvencel P, Tourneux P, Pérez T, Sauret A, Nelson JR, Brissaud O, Demarquez JL. Cathéters centraux et épanchements péricardiques en période néonatale : étude rétrospective multicentrique. Arch Pediatr 2005; 12:1456-61. [PMID: 16084702 DOI: 10.1016/j.arcped.2005.06.005] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2004] [Accepted: 06/04/2005] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To evaluate the use of neonatal central venous catheters (CVC) in 38 french neonatal units and occurrence of pericardial effusion (PCE) over the past 5 years. MATERIALS AND METHODS We surveyed 38 units with a questionnaire and studied the cases of PCE in five units. RESULTS Response rate was 89% (34/38). Accepted CVC tip positions were: junction of right atrium (RA) and vena cava (VC) 76%, VC 58%, RA 11%. Fifty percent of the centers had been exposed to PCE. 16 cases of PCE were studied. Median gestational age was 31 weeks (range: 26.1 to 40 weeks). Median time from insertion: 3.2 days (range: 0.4-13.5). In all cases CVC tip was intracardiac at insertion with inadequate withdrawing in 13 cases. Sudden cardiac collapse was reported in eight cases, and unexplained cardiorespiratory instability in six cases. Echography showed PCE in 14 cases. One diagnosis was post-mortem. CVC was withdrawn in 12 patients and 13 underwent pericardiocentesis. Four patients died and two had neurological sequelae. CONCLUSION PCE was associated with intracardiac CVC tip. The CVC tip should be controlled with radiography or echography outside the cardiac silhouette. PCE diagnosis must be considered in face of unexplained cardiovascular decompensation of neonate with CVC.
Collapse
Affiliation(s)
- P Jouvencel
- Service de pédiatrie et néonatologie, 13, avenue Interne J.-Loëb, centre hospitalier de la Côte Basque, 64100 Bayonne, France.
| | | | | | | | | | | | | |
Collapse
|
12
|
Hubiche T, Boralevi F, Jouvencel P, Taïeb A, Leaute-Labreze C. [Reticular erythema signalling the onset of episodes of hereditary angioedema in a child]. Ann Dermatol Venereol 2005; 132:249-51. [PMID: 15924048 DOI: 10.1016/s0151-9638(05)79255-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
INTRODUCTION Hereditary angioedema is characterized by episodes of subcutaneous, digestive or laryngeal edema. In some cases, non-pruritic reticular erythema may precede the episodes of edema. OBSERVATION Every 4 to 6 weeks since infancy, a girl presented non-pruritic widespread reticular erythema, sparing the face. Two or three times every year, abdominal pain or edema of the lower limb joints followed the skin eruption. At 12 years of age, she was hospitalized because of an edema of the face associated with the eruption. Exploration of the complement confirmed the diagnosis of type I hereditary angioedema. DISCUSSION The mean delay before diagnosis of hereditary angioedema is of 7 years. Reticular erythema in hereditary angioedema is frequent (40p. 100 of cases) and it usually occurs early in childhood, even in the absence of any episode of angioedema. When present, these eruptions usually precede an episode of angioedema. Recognition of this eruption as a symptom of hereditary angioedema would shorten the delay before diagnosis and anticipate appropriate management of the episodes.
Collapse
Affiliation(s)
- T Hubiche
- Unité de Dermatologie pédiatrique, Hôpital Pellegrin-Enfants, Place Amélie Raba-Léon, 33076 Bordeaux Cedex
| | | | | | | | | |
Collapse
|
13
|
Tourneux P, Jouvencel P, Micheau M, Jouvencel AC, Chateil JF, Barba G, Letavernier B, Llanas B. [Parvovirus B19 thrombocytopenic purpura complicated with a cerebral hemorrhage]. Arch Pediatr 2005; 12:281-3. [PMID: 15734124 DOI: 10.1016/j.arcped.2004.11.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2003] [Accepted: 11/12/2004] [Indexed: 10/25/2022]
Abstract
UNLABELLED Severe hemorrhage complications are rare in idiopathic thrombocytopenic purpura. This pathology is often considered as benign. CASE REPORT We report the case of a four-year-old boy presenting a parvovirus B19 idiopathic thrombocytopenic purpura. Despite early and repeated use of intravenous immunoglobulin, the evolution was characterized by the secondary apparition of a cerebral hemorrhage. It was lethal seven days after the initial diagnosis. CONCLUSION Parvovirus B19 should be investigated as an etiologic agent of idiopathic thrombocytopenic purpura, using PCR. The unpredictive aspect of severe hemorrhage complications, especially cerebral hemorrhages, explains the potential severity of this disease.
Collapse
Affiliation(s)
- P Tourneux
- Service de médecine néonatale et réanimation pédiatrique polyvalente, CHU d'Amiens, hôpital Nord, 1, place Victor-Pauchet, 80054 Amiens cedex 1, France.
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Coste C, Jouvencel P, Debuch C, Argote C, Lavrand F, Feghali H, Brissaud O. [Delayed discovery of congenital diaphragmatic hernia: diagnostic difficulties. A report of two cases]. Arch Pediatr 2004; 11:929-31. [PMID: 15288084 DOI: 10.1016/j.arcped.2004.04.018] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2003] [Accepted: 04/19/2004] [Indexed: 10/26/2022]
Abstract
Delayed revelation of congenital diaphragmatic hernias (CDH) is not uncommon and can represent 5-30% of total CDHs. Time before diagnosis may be prolonged, sometimes to the adult period. Respiratory and gastrointestinal symptoms are frequent but not specific. The clinical presentation of delayed CDH may thus mislead the practitioner. Diagnosis can be approached and/or confirmed by plain radiography. Outcome is usually favorable after surgery. We report two cases of delayed CDH and we discuss the difficulty of diagnosis.
Collapse
Affiliation(s)
- C Coste
- Service des urgences, centre hospitalier général de Langon, 33210 Langon, France
| | | | | | | | | | | | | |
Collapse
|
15
|
Harambat J, Sanson S, Lamireau D, Jouvencel P, Maurice-Tison S, Pillet P. 23 Connaissance et prévention du syndrome du bébé secoué au sein d’une population de parents de la maternité du CHU de bordeaux. ACTA ACUST UNITED AC 2004. [DOI: 10.1016/s0368-2315(04)96491-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
16
|
|
17
|
Imbert P, Gérardin P, Rogier C, Jouvencel P, Brousse V, Guyon P, Ka AS. [Pertinence of the 2000 WHO criteria in non-immune children with severe malaria in Dakar, Senegal ]. Bull Soc Pathol Exot 2003; 96:156-60. [PMID: 14582287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
UNLABELLED The relevance of World Health Organization (WHO) criteria for severe malaria has not been assessed in non-immune children. The objectives of this study were (i) to evaluate the significance of 1990 WHO definition reconsidered in 2000 on distribution and lethality of severe cases in children admitted with falciparum malaria, and (ii) to contribute to the study of relevance of the WHO severe criteria in Dakar, an hypoendemic area in Senegal. PATIENTS AND METHODS The 1990 WHO criteria, respiratory distress and platelet counts were prospectively collected in 1997-99 from children admitted to Hôpital Principal de Dakar, Senegal, with falciparum malaria diagnosed on a thick blood film. This method allowed also the definition of severe cases according to 2000 WHO criteria. RESULTS Among 311 patients (median age: 8 years old), according to the 2000 WHO criteria, the frequency of severe malaria cases was increased by 23% (75% versus 52%) and case-fatality rates thereof were decreased by 5% (17% versus 12%) compared with 1990 WHO definition. One death occurred among cases defined as severe on admission only according to criteria modified by WHO in 2000. A multivariate logistic regression model identified several independent prognostic factors: cerebral malaria, hypoglycaemia, respiratory distress, renal failure, collapse, abnormal bleedings, pupillary abnormalities and thrombocytopaenia defined as a platelet count below 100,000/mm3. A significant association (p < 0.001) was observed between platelet count increase and consciousness level improvement, evaluated on day of first platelet count control (time from admission: 1-7 d). Among survivors, a lesser improvement in coma score was associated with a decrease in platelet counts (p < 0.04). CONCLUSIONS The 1990 WHO criteria, which predicted death among malaria cases in children living under stable falciparum transmission, are relevant in this series of non-immune children living in a low and seasonal transmission. Nevertheless new WHO criteria showed poor prognostic significance. However, the 2000 WHO definition was highly sensitive to detect severe malaria cases. These findings should be considered for managing severe malaria in migrant children.
Collapse
Affiliation(s)
- P Imbert
- Service de pédiatrie, Hôpital principal, Dakar, Sénégal
| | | | | | | | | | | | | |
Collapse
|
18
|
Jouvencel P, Fayon M, Choukroun ML, Carles D, Montaudon D, Dumas E, Begueret H, Marthan R. Montelukast does not protect against hyperoxia-induced inhibition of alveolarization in newborn rats. Pediatr Pulmonol 2003; 35:446-51. [PMID: 12746941 DOI: 10.1002/ppul.10297] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Impaired lung development has been demonstrated in neonatal animals exposed to hyperoxia. High lung cys-leukotriene levels may be a contributing factor towards the increase in oxygen toxicity. We investigated the effect of cysteinyl-leukotriene inhibition using the receptor antagonist, montelukast (MK, Singulair), on hyperoxia-induced changes in lung parenchymal structure in neonatal rat pups. Rat pups were exposed to 21% O(2) (air) or 50% O(2) (moderate hyperoxia) from days 1-14 after birth, and were administered the cys-leukotriene receptor antagonist MK (1 mg/kg/day) or normal saline from days 4-14. Somatic growth and morphometric measurements were done on day 15. There was a significant increase in bronchoalveolar lavage fluid cysteinyl-leukotriene levels (+61.9%) when animals were exposed to hyperoxia. O(2) exposure significantly decreased the specific internal surface area by 13%. There was a nonsignificant 5.8% and 19.6% increase in mean chord length and mean alveolar diameter, respectively, as well as an 8.6% decrease in lung volume to body weight ratio. Inhibition of only one arm of the arachidonic-acid cascade by MK was not sufficient to prevent these oxygen-induced changes.
Collapse
Affiliation(s)
- Philippe Jouvencel
- Pediatric Intensive Care and Pulmonology Unit, Hôpital Pellegrin-Enfants, Bordeaux, France
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Jouvencel P, Lamireau D, Devars F, Sarlangue J. P85 Pneumologie - Cardiologie Atresie des choanes: Heterogeneite clinique et difficultes therapeutiques. Arch Pediatr 2003. [DOI: 10.1016/s0929-693x(03)90597-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
20
|
Gérardin P, Rogier C, Ka AS, Jouvencel P, Brousse V, Imbert P. Prognostic value of thrombocytopenia in African children with falciparum malaria. Am J Trop Med Hyg 2002; 66:686-91. [PMID: 12224575 DOI: 10.4269/ajtmh.2002.66.686] [Citation(s) in RCA: 118] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Thrombocytopenia is a common finding in malaria, but its prognostic value has not been addressed in children. The relationship between thrombocytopenia (platelet count < 100,000/mm3 on admission) and severity and outcome was investigated prospectively in children hospitalized with falciparum malaria in Dakar, Senegal, an area that is hypoendemic for malaria. Of 288 falciparum cases, 215 matched the 2000 World Health Organization definition of severe malaria. Median platelet counts were lower (98,000/mm3 versus 139,000/mm3; P < 0.02) among severe cases than in mild cases, and in children who died than among those who recovered (68,500/mm3 versus 109,000/mm3; P < 0.002). In severe cases, children presenting with a platelet count < 100,000/mm3 were more likely to die (odds ratio [OR] = 6.31, 95% confidence interval [CI] = 2.0-26.0). Moreover, multivariate analysis identified thrombocytopenia as an independent predictor of death (OR = 13.3, 95% CI = 3.2-55.1). Our data show an association between thrombocytopenia and either severity or prognosis in childhood falciparum malaria.
Collapse
|
21
|
Abstract
Glucocorticoids are widely used in perinatology, since they decrease the incidence of respiratory distress syndrome and chronic lung disease. However, evidence is now increasing that their use in this age group may result in impaired alveolar lung growth and general development. The aim of this study was to determine whether a low dose of hydrocortisone (1 mg/kg/day for 11 days) was deleterious to lung growth in rat pups, as compared to an equivalent dose of dexamethasone. While both dexamethasone and hydrocortisone increased alveolar diameter with thinning of the interairspace walls, only dexamethasone reduced the overall internal surface area of the lung available for respiratory exchange. Changes were more marked with dexamethasone as compared to hydrocortisone, which did not appear to affect alveolar septation. In conclusion, a prolonged course of low-dose hydrocortisone may be deleterious for alveolar lung growth in rat pups, but the changes are less marked than those caused by dexamethasone.
Collapse
Affiliation(s)
- Michael Fayon
- Pediatric Intensive Care and Pulmonology Unit and Centre de Recherche, Hôpital Pellegrin-Enfants, Bordeaux, France.
| | | | | | | | | |
Collapse
|
22
|
Imbert P, Gérardin P, Rogier C, Ka AS, Jouvencel P, Brousse V, Guyon P. Severe falciparum malaria in children: a comparative study of 1990 and 2000 WHO criteria for clinical presentation, prognosis and intensive care in Dakar, Senegal. Trans R Soc Trop Med Hyg 2002; 96:278-81. [PMID: 12174779 DOI: 10.1016/s0035-9203(02)90099-4] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The relevance of WHO criteria for severe and complicated malaria has been debated for a while, especially as regards children. Recent data led WHO experts to modify the definition of severe malaria. The objective of this study was to evaluate retrospectively the significance of the new definition on severity, lethality and intensive care distribution in children admitted with falciparum malaria (in 1997-99) to Hôpital Principal de Dakar, Senegal. We used the paediatric risk of mortality score (PRISM) to compare the 2 definitions, WHO 2000 and WHO 1990. Finally, we evaluated the impact of the new definition in terms of major therapeutic interventions (MTIs): mechanical ventilation, haemodynamic support, transfusion, haemodialysis, and the use of sedatives. Among 311 patients, the frequencies of severe malaria cases and case-fatality rates thereof were 52% (n = 161) and 17% (n = 28) respectively using the 1990 WHO criteria, and 75% (n = 233) and 12% (n = 28) using the 2000 WHO criteria. Mean PRISM score among severe cases decreased with the new definition (6.5 versus 8.6). Both definitions predicted neurological sequelae and deaths with 100% sensitivity. One or more MTIs were required in severe malaria cases in 86% (n = 139) under the 1990 criteria and 73% (n = 170) under the 2000 criteria. In this area of low and seasonal transmission, the 2000 WHO definition of severe malaria proved broader and less specific, but was easier to apply and retained the high sensitivity of the earlier definition in identifying life-threatening infections.
Collapse
Affiliation(s)
- P Imbert
- Service des Maladies Infectieuses et Tropicales, Hôpital d'Instruction des Armées Bégin, 69 Avenue de Paris, 94163 Saint-Mandé, France.
| | | | | | | | | | | | | |
Collapse
|
23
|
Jouvencel P, Brun M, Le Manh C, Micheau M, Sarlangue J. [Radiology case of the month. A case of congenital osteopetrosis]. Arch Pediatr 2000; 7:402-4. [PMID: 10793929 DOI: 10.1016/s0929-693x(00)88837-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- P Jouvencel
- Unité de néonatologie B, Hôpital Pellegrin-Enfants, Bordeaux, France
| | | | | | | | | |
Collapse
|
24
|
Jouvencel P, Vaillant C, Peyraud J, Cadier L, Brun L, Weil F, Pillet P, Pedespan J. Les atteintes de la substance blanche avec toxocarose serolog1que: A propos de deux observations. Arch Pediatr 1997. [DOI: 10.1016/s0929-693x(97)86633-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|